Promote Your Attorney Profile on Law.net - Get Found / Earn More!
Tiger Costume Fools Police, Man Charged with Possessing Bestiality Porn
Tiger Costume Fools Police, Man Charged with Possessing Bestiality Por...
Former CIO of Mayer Brown Sentenced to 27 Months in Prison
Former CIO of Mayer Brown Sentenced to 27 Months in Prison
Joan Rivers’ Death Investigated by NYC Law Firm
Joan Rivers’ Death Investigated by NYC Law Firm
Lawsuit Could Shake Maine’s Quarantine Laws
Lawsuit Could Shake Maine’s Quarantine Laws
Legal Job Listings

A Day Late and a Billion Dollars Short: Will the Medicines Co. Get to Keep its Patent?

In 2001, the Medicines Company just missed the application deadline for a patent extension for its main product, Angiomax, a blood thinner. Because of this error, the patent on the product will expire next week instead of in 2014.

And, because sales of Angiomax account for virtually all of Medicines’ revenue, the company has spent millions of dollars, and the last nine years trying to undo this error. In essence, the patent precludes the production of a comparable generic drug from being made.

According to the March 18 New York Times article, Clive A. Meanwell, Medicines’ chief executive was quoted as saying: “It’s a draconian penalty for an administrative mistake.”

The company spent $4.4 million on lobbyists just in 2009, according to the Center for Responsive Politics.

Get JD Journal in Your Mail
Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!




Medicines appealed two times to the United States Patent and Trademark Office, then sued when the appeals were rejected. The company also hired lobbyists to try to get federal legislation passed that critics called “The Dog Ate My Homework Act” that would retroactively permit the patent office to accept the company’s late application.

On Tuesday, Judge Claude M. Hilton of the United States District Court in Alexandria, Va. ordered the patent office to reconsider the rejection of Medicines’ 2001 filing. The ruling also ordered the patent office to ensure the Angiomax patent did not expire during the reconsideration period.

The Medicines Company says two law firms botched the application to the patent office, and is in talks with them about recovering damages, according to the same New York Times article.

The Medicines Company is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace.

A Day Late and a Billion Dollars Short: Will the Medicines Co. Get to Keep its Patent? by

Tagged: , , , , , , , , , ,

Posted by on March 19, 2010. Filed under Home,Legal News. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

 

 

Job of the Day
Supervising Attorney
USA-CA-Pacoima

Be a part of history!  Join the Neighborhood Legal Services of Los Angeles County (NLSLA) and become part of an energetic team of advocates that provides a wide-range of legal services  addr...

Related Posts: